Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.

Documenti analoghi

• Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
  di: Lisziewicz, J, et al.
  Pubblicazione: (1992)
• Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
  di: Agrawal, S, et al.
  Pubblicazione: (1989)
• Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
  di: Lisziewicz, J, et al.
  Pubblicazione: (1994)
• Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
  di: Li, G, et al.
  Pubblicazione: (1993)
• Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains.
  di: Rapaport, E, et al.
  Pubblicazione: (1996)